- Japan
- /
- Healthcare Services
- /
- TSE:9214
A Look At The Fair Value Of Recovery International Co.,Ltd. (TSE:9214)
Key Insights
- Using the 2 Stage Free Cash Flow to Equity, Recovery InternationalLtd fair value estimate is JP¥1,895
- With JP¥1,543 share price, Recovery InternationalLtd appears to be trading close to its estimated fair value
In this article we are going to estimate the intrinsic value of Recovery International Co.,Ltd. (TSE:9214) by taking the forecast future cash flows of the company and discounting them back to today's value. Our analysis will employ the Discounted Cash Flow (DCF) model. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow.
We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you.
Check out our latest analysis for Recovery InternationalLtd
What's The Estimated Valuation?
We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To start off with, we need to estimate the next ten years of cash flows. Seeing as no analyst estimates of free cash flow are available to us, we have extrapolate the previous free cash flow (FCF) from the company's last reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars:
10-year free cash flow (FCF) estimate
2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |
Levered FCF (¥, Millions) | JP¥111.8m | JP¥115.1m | JP¥117.5m | JP¥119.3m | JP¥120.7m | JP¥121.7m | JP¥122.5m | JP¥123.2m | JP¥123.7m | JP¥124.1m |
Growth Rate Estimate Source | Est @ 4.12% | Est @ 2.94% | Est @ 2.12% | Est @ 1.54% | Est @ 1.14% | Est @ 0.86% | Est @ 0.66% | Est @ 0.52% | Est @ 0.43% | Est @ 0.36% |
Present Value (¥, Millions) Discounted @ 4.7% | JP¥107 | JP¥105 | JP¥102 | JP¥99.3 | JP¥95.9 | JP¥92.4 | JP¥88.8 | JP¥85.3 | JP¥81.8 | JP¥78.4 |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = JP¥936m
After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (0.2%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 4.7%.
Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = JP¥124m× (1 + 0.2%) ÷ (4.7%– 0.2%) = JP¥2.8b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= JP¥2.8b÷ ( 1 + 4.7%)10= JP¥1.7b
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is JP¥2.7b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of JP¥1.5k, the company appears about fair value at a 19% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.
Important Assumptions
Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Recovery InternationalLtd as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 4.7%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for Recovery InternationalLtd
- Debt is not viewed as a risk.
- Earnings growth over the past year underperformed the Healthcare industry.
- Current share price is below our estimate of fair value.
- Lack of analyst coverage makes it difficult to determine 9214's earnings prospects.
- No apparent threats visible for 9214.
Looking Ahead:
Although the valuation of a company is important, it is only one of many factors that you need to assess for a company. The DCF model is not a perfect stock valuation tool. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. For Recovery InternationalLtd, we've put together three important aspects you should look at:
- Risks: Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Recovery InternationalLtd , and understanding it should be part of your investment process.
- Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!
- Other Top Analyst Picks: Interested to see what the analysts are thinking? Take a look at our interactive list of analysts' top stock picks to find out what they feel might have an attractive future outlook!
PS. Simply Wall St updates its DCF calculation for every Japanese stock every day, so if you want to find the intrinsic value of any other stock just search here.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:9214
Recovery InternationalLtd
Offers home-visit nursing and rehabilitation in-home nursing care services in Japan.
Adequate balance sheet with questionable track record.